Quick verdict
Henry Meds is the better pick for most patients on overall scoring. Henry built the cash-pay compounded GLP-1 category and still runs the cleanest version of it. Flat monthly pricing, no labs theater, true month-to-month. Pivoted hard after the FDA shortage delisting and now leans on personalization-claim 503A pharmacies.
That said, Found wins on specific dimensions. Found has the broadest medication catalog of any program here, including off-label tirzepatide and orforglipron access through their Foundayo program. The 6-month non-refundable subscription is the catch.
Side-by-side
| Found | Henry Meds | |
|---|---|---|
| Starts from | $99/mo (+ med separate) | $297/mo (incl. medication) |
| Lock-in | 6-month lock-in | Month-to-month |
| Time to prescription | 5 days | 2 days |
| Consultation type | Asynchronous | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Found | Henry Meds | |
|---|---|---|
| Pricing transparency | 6/10 | 8/10 |
| Cancellation terms | 3/10 | 9/10 |
| Onboarding experience | 8/10 | 8/10 |
| Medication options | 9/10 | 6/10 |
| Member outcomes | 5/10 | 7/10 |
When to choose Found
Patients whose obesity medicine clinician has flagged a non-standard medication path (multiple drug classes, off-label combinations, or 503A-compounded options that other programs have exited).
When to choose Henry Meds
Buyers who want predictable flat-rate compounded semaglutide with no commitments and minimal friction.
FAQ
Is Found cheaper than Henry Meds?
Can I switch from Found to Henry Meds mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →